Skip to main content
Pharmaceutics logoLink to Pharmaceutics
. 2025 Mar 14;17(3):369. doi: 10.3390/pharmaceutics17030369

Correction: Kuskov et al. Amphiphilic Poly-N-vinylpyrrolidone Nanoparticles as Carriers for Nonsteroidal, Anti-Inflammatory Drugs: Pharmacokinetic, Anti-Inflammatory, and Ulcerogenic Activity Study. Pharmaceutics 2022, 14, 925

Andrey Kuskov 1,2, Dragana Nikitovic 3,*, Aikaterini Berdiaki 3, Mikhail Shtilman 2, Aristidis Tsatsakis 4
PMCID: PMC11945146  PMID: 40143059

Error in Figure

In the original publication [1], there was a mistake in Figure 7 as published. The wrong image for Figure 7A was included. The corrected Figure 7 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Figure 7.

Figure 7

The effect of free and loaded to PVP-OD4000 IMC oral administration on rat stomach mucosa. (A) Hollow PVP-OD4000; (B) free IMC 40 mg/kg BW); (C) IMC loaded to PVP-OD4000 40 mg/kg BW; (D) IMC loaded to PVP-OD4000 60 mg/kg BW.

Footnotes

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Reference

  • 1.Kuskov A., Nikitovic D., Berdiaki A., Shtilman M., Tsatsakis A. Amphiphilic Poly-N-vinylpyrrolidone Nanoparticles as Carriers for Nonsteroidal, Anti-Inflammatory Drugs: Pharmacokinetic, Anti-Inflammatory, and Ulcerogenic Activity Study. Pharmaceutics. 2022;14:925. doi: 10.3390/pharmaceutics14050925. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Pharmaceutics are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES